Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality

Infection Control and Hospital Epidemiology

Volumn 20, Issue 5, 1999, Pages 318-323

  Lautenbach, Ebbing ^a   Bilker, Warren B ^a   Brennan, Patrick J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; COHORT ANALYSIS; COMORBIDITY; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; UNITED STATES; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; COMORBIDITY; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PHILADELPHIA; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS; VANCOMYCIN;

EID: 0033128729     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501624     Document Type: Article

References (12)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):72S-75S.
2. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91(suppl 3B):86S-89S.
3. Landry SL, Kaiser DL, Wenzel RP. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989;17:323-329.
4. Toala P, McDonald A, Wilcox C, Finland M. Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci 1969;258:416-430.
5. Uttley AHC, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;I:57-58. Letter.
6. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR 1993;42:597-599.
7. Noble WC, Virani Z, Cree R Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus. FEMS Microbiology Letters 1992;93:195-198.
8. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995:20:296-301.
9. Noskin GA, Till M, Patterson BK, Clarke JT, Warren JR. High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis 1991;164:1212-1215.
10. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium. Clin Infect Dis 1996;22:663-670.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:3141.
12. Weinstein MP, Murphy JR, Relier LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults; II: clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54-70.